Identity
- Security key
- 20296
- Ticker
- PPCB
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2012-06-15
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- PPCB
Detail
Enriched 2026-08-14 20:47
- Market cap
- $2,756,828.91
- Shares outstanding (class)
- 3,503,116
- Shares outstanding (weighted)
- 2,278,371
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 2
- Location
- CAMBERWELL, VICTORIA, C3
- Homepage
- https://www.propanc.com
- Description
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Market cap and share counts drift.